Therapy Architects

Area Served

About Therapy Architects

Therapy Architects designs and develops novel targeted cancer therapies for both children and adults. Every patient is unique and not all respond to available products. Our team is focused on improving outcomes by optimizing efficacy and reducing toxic side effects of chemotherapeutic agents where, the cure can sometimes be worse than the disease itself. Dr. Rajasekaran was a postdoctoral fellow in the laboratory of Drs. David Sabatini and Gert Kreibich at NYU medical center where he studied basic mechanisms of protein translation and translocation across endoplasmic reticulum. He did a second postdoctoral fellowship with Dr. Enrique Rodriquez-Boulan at the Weill Medical College of Cornell University where he studied protein sorting in polarized epithelial cells. Here, he developed interest in epithelial tight junctions and discovered a novel mechanism of protein targeting to the tight junction. At Cornell he invented a microprocessor controlled cell homogenizer and other devices for molecular biology research. At the University of California, Los Angeles he made many seminal basic and translational cancer research findings. His research demonstrated that the beta-subunit of sodium pump (an enzyme involved in sodium and potassium ion homeostasis) is a cell adhesion molecule and is lost when normal cells transforms into cancer cells. For more details contact us.